Fig. 2.

DABIL‐4 shows antitumor activity in 4T1 adenocarcinoma model in Balb/c mice. (A) Schematic of the experiment. Treatment was given thrice weekly on days 7, 9, 12, 14, 16, 19, 21, and 23 post‐tumor implantations. (B) DABIL‐4 administration led to the decline in tumor volume (n = 5), (C) tumor weight (n = 5), and (D) lung metastasis (n = 3) both qualitatively and (E) quantitatively. Statistical significance for tumor growth and lung metastasis experiments was assessed by two‐tailed unpaired Student's t‐test considering an unequal distribution. Tumors were measured by electronic Vernier calipers. Red arrows indicate the days when treatment was administered. Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001.